tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Invivyd announces full Phase 1/2 clinical data for VYD2311
PremiumThe FlyInvivyd announces full Phase 1/2 clinical data for VYD2311
26d ago
Invivyd’s Strategic Growth and Expansion Beyond COVID-19: Buy Rating Maintained Despite Revenue Shortfall
Premium
Ratings
Invivyd’s Strategic Growth and Expansion Beyond COVID-19: Buy Rating Maintained Despite Revenue Shortfall
2M ago
Invivyd price target lowered to $5 from $10 at H.C. Wainwright
Premium
The Fly
Invivyd price target lowered to $5 from $10 at H.C. Wainwright
2M ago
Invivyd Reports Q1 2025 Financial Results and Outlook
PremiumCompany AnnouncementsInvivyd Reports Q1 2025 Financial Results and Outlook
2M ago
Invivyd’s Earnings Call: Strategic Moves Amid Challenges
Premium
Company Announcements
Invivyd’s Earnings Call: Strategic Moves Amid Challenges
2M ago
Invivyd Reports Q1 2025 Financial Results and Highlights
Premium
Company Announcements
Invivyd Reports Q1 2025 Financial Results and Highlights
2M ago
Invivyd Launches Program for Measles Antibody Treatment
PremiumCompany AnnouncementsInvivyd Launches Program for Measles Antibody Treatment
2M ago
Invivyd Secures $30 Million Loan from SVB
Premium
Company Announcements
Invivyd Secures $30 Million Loan from SVB
3M ago
Invivyd announces $30M non-dilutive loan facility
Premium
The Fly
Invivyd announces $30M non-dilutive loan facility
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100